Page last updated: 2024-08-17

levodopa and ro 41-1049

levodopa has been researched along with ro 41-1049 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Fernandes, MH; Pestana, M; Soares-da-Silva, P1
Fernandes, MH; Soares-da-Silva, P1
Pestana, M; Soares-da-Silva, P1
Brannan, T; Prikhojan, A; Yahr, MD1
Fernandes, MH; Soares-da-Silva, P; Vieira-Coelho, MA1
d'Agostini, F; Damsma, G; DaPrada, M; DeBoer, P; Heeringa, MJ1
Archer, T; Fredriksson, A; Palomo, T1

Other Studies

8 other study(ies) available for levodopa and ro 41-1049

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Deamination of newly-formed dopamine in rat renal tissues.
    British journal of pharmacology, 1991, Volume: 102, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Deamination; Dopamine; In Vitro Techniques; Kidney; Levodopa; Male; Pargyline; Picolinic Acids; Rats; Rats, Wistar; Thiazoles

1991
Role of monoamine oxidase A and B in the deamination of newly-formed dopamine in the rat kidney.
    Journal of neural transmission. Supplementum, 1990, Volume: 32

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Deamination; Dopamine; In Vitro Techniques; Kidney; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Picolinic Acids; Rats; Rats, Inbred Strains; Thiazoles

1990
Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    British journal of pharmacology, 1994, Volume: 113, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Dopamine; In Vitro Techniques; Isoenzymes; Kidney Cortex; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Picolinic Acids; Rats; Rats, Wistar; Thiazoles

1994
Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: an in vivo study.
    Journal of neural transmission. Parkinson's disease and dementia section, 1994, Volume: 8, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Levodopa; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Thiazoles

1994
In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine.
    Journal of neural transmission. Supplementum, 1994, Volume: 41

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Kidney; Levodopa; Male; Monoamine Oxidase Inhibitors; Picolinic Acids; Rats; Rats, Wistar; Thiazoles; Tissue Distribution

1994
Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.
    Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:6-7

    Topics: Animals; Antiparkinson Agents; Benzophenones; Catechol O-Methyltransferase Inhibitors; Enzyme Inhibitors; Levodopa; Male; Monoamine Oxidase Inhibitors; Motor Activity; Nitrophenols; Oxidopamine; Picolinic Acids; Rats; Rotation; Thiazoles; Tolcapone

1997
Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa.
    Behavioural pharmacology, 2000, Volume: 11, Issue:7-8

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Phenelzine; Phenethylamines; Selegiline; Thiazoles; Tryptamines

2000